Press Release: Standard Textile Announces Sponsorship of the Launch of the 2019 IPUIP and Treatment CPG

The CPG is a consolidation of current evidence-based clinical practice recommendations from around the world for the prevention and treatment of pressure injuries.

CINCINNATI, Ohio (November 15, 2019) – Standard Textile announces its supporting sponsorship of the National Pressure Injury Advisory Panel’s (NPIAP) launch of the 2019 International Pressure Ulcer/Injury Prevention and Treatment Clinical Practice Guideline (CPG) on Friday, November 15-16, 2019 at the University of Southern California (USC) Campus in Los Angeles, Calif.

The Standard Textile team will present the company’s DermaTherapy^® Therapeutic Linen System at booth V12.

“Research shows that national efforts to reduce hospital-acquired conditions, such as adverse drug events and injuries from falls, has helped save thousands of lives and significantly reduced healthcare costs. However, pressure injuries remain on the rise, increasing by more than 6%¹,” said Norman Frankel, Executive Vice President, Standard Textile. “Millions of patients are impacted annually by pressure injuries and this is a preventable condition. We are pleased to support the launch of the new Clinical Practice Guideline and continue working with our healthcare partners to put an end to hospital-acquired pressure injuries.”

To create the 2019 International Guideline:

• Over 1,200 consumers from around the world completed surveys that identified their concerns and goals for pressure injury prevention and treatment.
• Fourteen international associate organizations partnered in the guideline development process.
• More than 3,500 research studies were reviewed to answer key clinical questions.

Silk-like fabric has been recognized and recommended in the NPIAP’s most recent Clinical Practice Guideline: “Consider using silk-like fabrics rather than cotton or cotton-blend fabrics to reduce shear and friction.”

DermaTherapy^® by Standard Textile is the first and only silk-like therapeutic linen system with FDA 510(k)^{2, 3} clearance as a Class I medical device to reduce the likelihood of patients developing pressure injuries.

For information, visit DermaTherapy.StandardTextile.com.

¹ Declines in Hospital-Acquired Conditions. Content last reviewed May 2019. Agency for Healthcare Research and Quality, Rockville, MD. https://www.ahrq.gov/data/infographics/hac-rates_2019.html

² FDA 510(K) Clearance No. K152884. Indications for Use: Bed linens made with DermaTherapy^® fabrics are intended for use by patients 18 years of age and older in hospital settings who are susceptible to pressure ulcers. The DermaTherapy^® Bed Linens help to reduce the likelihood of patients developing pressure ulcers by reducing moisture, friction and shear on the patient’s skin.

³ FDA 510(K) Clearance No. K061242. Indications for Use: Institutional Bedding (bed sheets and pillow cases) made with DermaTherapy^® fabrics is intended for use by patients in a hospital, healthcare or home setting who are susceptible to or may have mild atopic dermatitis.

DermaTherapy^® was developed in partnership between Standard Textile Co., Inc. and Precision Fabrics Group. DermaTherapy^® is a registered trademark of Precision Fabrics Group, Inc.

###

About Standard Textile
Founded in 1940, Standard Textile has developed a culture of innovation, quality, and service. With more than 70 patents, its products are engineered to deliver durability, longevity, and value. A vertically integrated company, Standard Textile is a leading global provider of total solutions in the institutional textiles and apparel markets. Leveraging textile design, manufacturing, and laundry expertise, and its global infrastructure, this company serves customers in the healthcare, hospitality, interiors, consumer, and workwear markets worldwide.

Contact:
Judy Sroufe
Vice President, Brand Marketing and Communications, Standard Textile
jsroufe@standardtextile.com
(513) 761-9256